AAV8-based gene replacement therapy for hereditary spastic paraplegia type 5
Linus Wiora(German Center for Neurodegenerative Diseases), Lüdger Schöls(German Center for Neurodegenerative Diseases)
Cited by 1
Related Papers
Clinical features, neurogenetics and neuropathology of the polyglutamine spinocerebellar ataxias type 1, 2, 3, 6 and 7
|Progress in Neurobiology|2013|360
Deep Intronic <i>FGF14</i> GAA Repeat Expansion in Late-Onset Cerebellar Ataxia
|New England Journal of Medicine|2022|243
Autosomal recessive spastic ataxia of Charlevoix Saguenay (ARSACS): expanding the genetic, clinical and imaging spectrum
|Orphanet Journal of Rare Diseases|2013|189
Mutation analysis and association studies of the UCHL1 gene in German Parkinsonʼs disease patients
|Neuroreport|2000|143
Novel homozygous p.E64D mutation in DJ1 in early onset Parkinson disease (PARK7)
|Human Mutation|2004|125